Month: January 2018
-
Technique Developed for High-Speed Antibody Screening
A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses.
-
Little Data to Support Wearable Device Health Benefits
A review of published research since 2000 shows little evidence to support claims of beneficial health outcomes from the use of wearable devices like smart watches or wristbands, at least not yet.
-
Small Business Grant Advances Drug Safety Test System
An award from National Institutes of Health is advancing a technology for testing the safety of drugs with heart muscle cells derived from stem cells before the drugs are tested on humans.
-
FDA to Release More Accessible Clinical Trial Data
The U.S. Food and Drug Administration plans to make available in a more user-friendly format details from clinical trials of new drugs approved by the agency.
-
Nerve Stimulation Shown to Reduce Diabetes Symptoms
Electric stimulation of a key nerve pathway was shown in lab animals to restore insulin sensitivity and glucose tolerance typically missing in people with type 2 diabetes.
-
Three Ways Tech Is Leveling The Playing Field Of Investing
If your idea of people that invest in the stock market is all cigars, pinstripe shirts and suspenders, you need to think again. The reason is new tech in this field means it’s no longer the domain of the filthy rich.
-
Medical Tech, Phone App Companies Partner on Wound Care
A company making wound care products is collaborating with a developer of mobile apps and analytics to design a more advanced diagnostics system for wounds.
-
How Technology Is Changing The Face of Politics
tâs easy to forget just how much of an impact politics has been affected by tech; we take a look at five ways it has.
-
Components Designed to Improve Genetic Circuits
Researchers in Houston, Texas created a set of components like those in electronics that help make synthetic gene circuits more accurate and predictable.
-
First MERS Virus Treatment Found Safe
An experimental treatment for Middle East respiratory syndrome, or MERS, infections made from antibodies produced in cattle is shown in a clinical trial to be safe for patients.